Showing results (61-70 of 204) with videos related to

Sort By:
Pageof 21
Chronic Obstructive Pulmonary Diseases (Miami, Fla.)|August 30, 2017
St George's Respiratory Questionnaire Score Predicts Outcomes in Patients with COPD: Analysis of Individual Patient Data in the COPD Biomarkers Qualification Consortium DatabaseHana Müllerova, Heather Gelhorn, Hilary Wilson, et al.
Chronic Obstructive Pulmonary Diseases (Miami, Fla.)|August 30, 2017
Socioeconomic Status as a Determinant of Health Status Treatment Response in COPD TrialsPaul W Jones, Heather Gelhorn, Hilary Wilson, et al.
Chronic Obstructive Pulmonary Diseases (Miami, Fla.)|January 31, 2020
Short Physical Performance Battery: What Does Each Sub-Test Measure in Patients with Chronic Obstructive Pulmonary Disease?Divya Mohan, Victoria S Benson, Matthew Allinder, et al.
The Lancet. Respiratory Medicine|June 7, 2017
A novel endpoint for exacerbations in asthma to accelerate clinical development: a post-hoc analysis of randomised controlled trialsAnne L Fuhlbrigge, Thomas Bengtsson, Stefan Peterson, et al.
BMJ Open Respiratory Research|June 14, 2023
Circulating testosterone levels and health outcomes in chronic obstructive pulmonary disease: results from ECLIPSE and ERICAHolly Pavey, Michael I Polkey, Charlotte E Bolton, et al.
Respiratory Research|August 1, 2020
Endotrophin, an extracellular hormone, in combination with neoepitope markers of von Willebrand factor improves prediction of mortality in the ECLIPSE COPD cohortSarah R Rønnow, Lasse L Langholm, Morten A Karsdal, et al.
American Journal of Respiratory and Critical Care Medicine|January 30, 2020
DNA Methylation Is Predictive of Mortality in Current and Former SmokersJarrett D Morrow, Barry Make, Elizabeth Regan, et al.
International Journal of Chronic Obstructive Pulmonary Disease|March 27, 2020
Increased von Willebrand Factor Processing in COPD, Reflecting Lung Epithelium Damage, Is Associated with Emphysema, Exacerbations and Elevated Mortality RiskLasse L Langholm, Sarah Rank Rønnow, Jannie M B Sand, et al.
Thorax|August 15, 2022
Tobacco industry ownership of pharmaceutical companies: an international survey of people with respiratory diseaseRuth Tal-Singer, Linda Walsh, Tim Deuby, et al.
Chest|November 26, 2016
Mechanisms of Vascular Dysfunction in COPD and Effects of a Novel Soluble Epoxide Hydrolase Inhibitor in SmokersLucy Yang, Joseph Cheriyan, David D Gutterman, et al.
Pageof 21